Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Antibody-mediated osseous regeneration: the early events in the healing response.

Freire MO, Kim HK, Kook JK, Nguyen A, Zadeh HH.

Tissue Eng Part A. 2013 May;19(9-10):1165-74. doi: 10.1089/ten.TEA.2012.0282. Epub 2013 Jan 8.

PMID:
23190409
2.

Functionalization of scaffolds with chimeric anti-BMP-2 monoclonal antibodies for osseous regeneration.

Ansari S, Moshaverinia A, Pi SH, Han A, Abdelhamid AI, Zadeh HH.

Biomaterials. 2013 Dec;34(38):10191-8. doi: 10.1016/j.biomaterials.2013.08.069. Epub 2013 Sep 19.

3.

Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies.

Freire MO, You HK, Kook JK, Choi JH, Zadeh HH.

Tissue Eng Part A. 2011 Dec;17(23-24):2911-8. doi: 10.1089/ten.tea.2010.0584. Epub 2011 Aug 26.

PMID:
21870943
4.

Immobilization of murine anti-BMP-2 monoclonal antibody on various biomaterials for bone tissue engineering.

Ansari S, Freire MO, Pang EK, Abdelhamid AI, Almohaimeed M, Zadeh HH.

Biomed Res Int. 2014;2014:940860. doi: 10.1155/2014/940860. Epub 2014 Jul 23.

5.

Application of AMOR in craniofacial rabbit bone bioengineering.

Freire M, Choi JH, Nguyen A, Chee YD, Kook JK, You HK, Zadeh HH.

Biomed Res Int. 2015;2015:628769. doi: 10.1155/2015/628769. Epub 2015 Jan 29.

6.

Effects of the orientation of anti-BMP2 monoclonal antibody immobilized on scaffold in antibody-mediated osseous regeneration.

Ansari S, Freire M, Choi MG, Tavari A, Almohaimeed M, Moshaverinia A, Zadeh HH.

J Biomater Appl. 2015 Nov;30(5):558-67. doi: 10.1177/0885328215594704. Epub 2015 Jul 15.

7.

Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.

Hyun SJ, Han DK, Choi SH, Chai JK, Cho KS, Kim CK, Kim CS.

J Periodontol. 2005 Oct;76(10):1667-74.

PMID:
16253088
8.

Biomechanical analysis of engineered bone with anti-BMP2 antibody immobilized on different scaffolds.

Ansari S, Phark JH, Duarte S Jr, Paulino da Silva M, Sharifzadeh N, Moshaverinia A, Zadeh HH.

J Biomed Mater Res B Appl Biomater. 2016 Oct;104(7):1465-73. doi: 10.1002/jbm.b.33492. Epub 2015 Aug 7.

PMID:
26252572
9.

Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.

Ahn SH, Kim CS, Suk HJ, Lee YJ, Choi SH, Chai JK, Kim CK, Han SB, Cho KS.

J Periodontol. 2003 Jun;74(6):787-97.

PMID:
12886988
11.

Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model.

Pelaez M, Susin C, Lee J, Fiorini T, Bisch FC, Dixon DR, McPherson JC 3rd, Buxton AN, Wikesjö UM.

J Clin Periodontol. 2014 Aug;41(8):827-36. doi: 10.1111/jcpe.12270. Epub 2014 Jun 9.

PMID:
24807100
12.
13.

The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2.

Sawyer AA, Song SJ, Susanto E, Chuan P, Lam CX, Woodruff MA, Hutmacher DW, Cool SM.

Biomaterials. 2009 May;30(13):2479-88. doi: 10.1016/j.biomaterials.2008.12.055. Epub 2009 Jan 21.

PMID:
19162318
14.

Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats.

Shin JH, Kim KH, Kim SH, Koo KT, Kim TI, Seol YJ, Ku Y, Rhyu IC, Chung CP, Lee YM.

J Clin Periodontol. 2010 Mar;37(3):305-11. doi: 10.1111/j.1600-051X.2009.01522.x. Epub 2009 Dec 21.

PMID:
20041973
15.

Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2.

Huang RL, Yuan Y, Tu J, Zou GM, Li Q.

Osteoarthritis Cartilage. 2014 Aug;22(8):1186-96. doi: 10.1016/j.joca.2014.06.017. Epub 2014 Jun 26.

16.

An in vivo study on the effect of scaffold geometry and growth factor release on the healing of bone defects.

Yilgor P, Yilmaz G, Onal MB, Solmaz I, Gundogdu S, Keskil S, Sousa RA, Reis RL, Hasirci N, Hasirci V.

J Tissue Eng Regen Med. 2013 Sep;7(9):687-96. doi: 10.1002/term.1456. Epub 2012 Mar 7.

PMID:
22396311
17.

A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model.

Behr B, Sorkin M, Lehnhardt M, Renda A, Longaker MT, Quarto N.

Tissue Eng Part A. 2012 May;18(9-10):1079-86. doi: 10.1089/ten.TEA.2011.0537. Epub 2012 Feb 28.

18.

Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.

Pang EK, Im SU, Kim CS, Choi SH, Chai JK, Kim CK, Han SB, Cho KS.

J Periodontol. 2004 Oct;75(10):1364-70.

PMID:
15562914
19.

Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering.

Moshaverinia A, Ansari S, Chen C, Xu X, Akiyama K, Snead ML, Zadeh HH, Shi S.

Biomaterials. 2013 Sep;34(28):6572-9. doi: 10.1016/j.biomaterials.2013.05.048. Epub 2013 Jun 14.

20.

Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects.

Oest ME, Dupont KM, Kong HJ, Mooney DJ, Guldberg RE.

J Orthop Res. 2007 Jul;25(7):941-50.

Items per page

Supplemental Content

Write to the Help Desk